Company Information & Drug Savings for Shionogi Pharma Medications
Shionogi is a Japanese pharmaceutical company with US operations in infectious diseases, pain management, and CNS disorders. The company developed cefiderocol (Fetroja) for multidrug-resistant gram-negative infections and baloxavir (Xofluza) for influenza. Shionogi’s infectious disease expertise addresses antimicrobial resistance and emerging viral threats.


How to Contact Shionogi Pharma
Medical Disclaimer
NowPatient has taken all reasonable steps to ensure that all material is factually accurate, complete, and current. However, the knowledge and experience of a qualified healthcare professional should always be sought after instead of using the information on this page. Before taking any drug, you should always speak to your doctor or another qualified healthcare provider.
The information provided here about medications is subject to change and is not meant to include all uses, precautions, warnings, directions, drug interactions, allergic reactions, or negative effects. The absence of warnings or other information for a particular medication does not imply that the medication or medication combination is appropriate for all patients or for all possible purposes.




